UTokyo Innovation Platform Co. Ltd. — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
CORE Biomedicine, Inc.corebiomedicine.comMar 2025
CORE Biomedicine is a biotech company developing precision cancer medicines based on cancer lineage biology, focused on advancing drug candidates from discovery into clinical development.
BiotechDigital HealthHealthtechMedical Devices
Ping Zhu(Co-founder & CEO)inGuozhu Zheng(Co-founder, President and CSO)Tarek Sahmoud(Chief Medical Officer)Douglas McMillin(Head of BD & Operations)
Co-investorsVision Incubate
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.